De Novo Biotherapeutics

Website
Current Valuation
N/A
As of November 22, 2024
Total Funding Raised
$8.4M
Last Round
Early Stage VC

Amount undisclosed

Last Funding
Nov 2024

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

De Novo Biotherapeutics is currently valued at N/A as of November 22, 2024. The company has raised a total of $8.4M in funding.

Track De Novo Biotherapeutics Valuation Updates

Get notified when De Novo Biotherapeutics raises new funding or valuation changes

Explore More Data
Detailed analysis for De Novo Biotherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock De Novo Biotherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is De Novo Biotherapeutics Worth in 2026?

De Novo Biotherapeutics is a leading private company in the technology sector. Track De Novo Biotherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How De Novo Biotherapeutics Valuation is Determined

Private company valuations like De Novo Biotherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.